Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 91-103
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.91
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.91
Table 1 Baseline demographic details and outcome parameters
| Characteristic | Overall cohort |
| Age, yr (mean ± SD) | 40 ± 13.6 |
| Sex (%) | |
| Males | 64.5 |
| Females | 35.5 |
| Etiology, n (%) | |
| Alcohol | 79 (51) |
| Gallstones | 63 (40.6) |
| ERCP | 6 (3.9) |
| Idiopathic | 5 (3.2) |
| Hyperparathyroidism | 2 (1.3) |
| Co-morbidities, n (%) | 32 |
| Diabetes mellitus | 19 (59.4) |
| Hypertension | 21 (65.6) |
| Coronary artery disease | 8 (25) |
| Chronic obstructive airway disease | 14 (43.7) |
| Obesity, n (%) | 18 (11.6%) |
| Severity, n (%) | |
| Moderately severe | 72 (46.4) |
| Severe | 83 (53.5) |
| Pain to PCD interval, d (median) | 24 |
| Site of collection, n (%) | |
| Lesser sac | 94 (62.6) |
| Paracolic gutter | 28 (18.7) |
| Lesser sac and paracolic gutter | 16 (10.7) |
| Perisplenic | 4 (2.7) |
| Perihepatic | 3 (2) |
| Pelvic | 5 (3.3) |
| Infected necrosis, n (%) | 75 (36.7) |
| Organ failure, n (%) | 100 (64.5) |
| Length of hospital stay, d (mean ± SD) | 22 ± 19.3 |
| Length of ICU stay, d (mean ± SD) | 6.1 ± 10.1 |
| Surgery, n (%) | 24 (15.4) |
| Endoscopic drainage, n (%) | 7 (4.5) |
| Mortality, n (%) | 32 (20.6) |
Table 2 Group statistics
| Parameters | Overall cohort (n = 155) | |||
| Characteristics | Compared variable | Group I | Group II | P value |
| Number | 109 | 46 | ||
| Pain to PCD interval | Mean | 39.8 | 54.1 | 0.249 |
| Site of collection (%) | Lesser sac | 64.2 | 52.2 | 0.464 |
| Paracolic | 16.5 | 21.7 | ||
| Lesser sac + paracolic | 11 | 8.7 | ||
| Procalcitonin | Mean | 3.2 | 5.4 | 0.331 |
| Collection size | Mean | 11.4 | 11.5 | 0.974 |
| Catheter size | < 12F | 23 | 8 | 0.598 |
| > 12F | 86 | 38 | ||
| RAC severity | Moderately severe | 62 | 11 | < 0.001 |
| Severe | 47 | 35 | ||
| Infected necrosis | No | 71 | 27 | 0.447 |
| Yes | 38 | 19 | ||
| Organ failure | No | 43 | 11 | 0.076 |
| Yes | 66 | 34 | ||
Table 3 Serial white blood cell count and neutrophil-lymphocyte ratio
| Day | n | Median | IQR (25%-75%) |
| WBC | |||
| 0 | 155 | 14.9 | 9.9-20.7 |
| 1 | 110 | 12.3 | 8.9-17.4 |
| 2 | 151 | 11.6 | 8.3-17.6 |
| 3 | 102 | 12.4 | 8.9-16.2 |
| NLR | |||
| 0 | 140 | 8.2 | 5.2-14.1 |
| 1 | 88 | 7.2 | 4.4-12 |
| 2 | 136 | 6.4 | 4.1-11.9 |
| 3 | 89 | 6.6 | 3.8-12.1 |
Table 4 Area under the curve for serial white blood cell count and neutrophil-lymphocyte ratio for differentiating responders from non-responders to percutaneous catheter drainage
| Time point | WBC | NLR |
| Baseline (0) | 0.508 | 0.401 |
| 24 h (1) | 0.602 | 0.682 |
| 48 h (2) | 0.468 | 0.407 |
| 72 h (3) | 0.416 | 0.427 |
- Citation: Gupta P, Das GC, Bansal A, Samanta J, Mandavdhare HS, Sharma V, Naseem S, Gupta V, Yadav TD, Dutta U, Varma N, Sandhu MS, Kochhar R. Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitis. World J Clin Cases 2022; 10(1): 91-103
- URL: https://www.wjgnet.com/2307-8960/full/v10/i1/91.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.91
